Clinical Trial

Unexplained Recurrent Pregnancy Loss: New Therapeutic Perspectives

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Evaluation of gut permeability and endometrial inflammasome NLRP3 in women with unexplaid recurrent pregnancy loss before-after administration of Bifidobacteriumlongum ES1.
Trial Details
NCT Number NCT06867900
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Miscarriage, Recurrent
Enrollment 22 participants
Start Date 2021-01-01
Primary Completion 2023-07-05 (estimated)
Study Completion 2025-07-06 (estimated)
Updated on ClinicalTrials.gov 2025-03-10